Search research articles
Contact Us
Filters
Showing results (161-170 of 193) with videos related to
Page
of 20
Sort By:
Circulation
|
March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
European Heart Journal
|
August 17, 2019
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9
Hyun-Duk Jang, Sang Eun Lee, Jimin Yang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 14, 2024
Renal Function-Stratified Comparison of Short- and Long-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention With Third-Generation Drug-Eluting Stents - Post Hoc Analysis From the HOST-IDEA Randomized Clinical Trial
Jung-Kyu Han, Seung Do Lee, Doyeon Hwang, et al.
Circulation. Cardiovascular Interventions
|
May 24, 2024
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial
Jung-Kyu Han, Seokhun Yang, Doyeon Hwang, et al.
JAMA Cardiology
|
November 27, 2024
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity
Jeehoon Kang, Jaewook Chung, Kyung Woo Park, et al.
Eclinicalmedicine
|
January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
BMJ Open
|
October 14, 2017
Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis - coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trial
Chi-Hoon Kim, Jung-Kyu Han, Han-Mo Yang, et al.
Biomaterials
|
December 23, 2019
NFATc1+CD31+CD45- circulating multipotent stem cells derived from human endocardium and their therapeutic potential
Han-Mo Yang, Ju-Young Kim, Hyun-Jai Cho, et al.
European Journal of Heart Failure
|
May 7, 2014
A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry
Sang Eun Lee, Hyun-Jai Cho, Hae-Young Lee, et al.
The American Journal of Cardiology
|
September 30, 2020
Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Jiesuck Park, Jung-Kyu Han, Jeehoon Kang, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 193) with videos related to
Sort By:
Page
of 20
Circulation
|
March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
European Heart Journal
|
August 17, 2019
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9
Hyun-Duk Jang, Sang Eun Lee, Jimin Yang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
October 14, 2024
Renal Function-Stratified Comparison of Short- and Long-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention With Third-Generation Drug-Eluting Stents - Post Hoc Analysis From the HOST-IDEA Randomized Clinical Trial
Jung-Kyu Han, Seung Do Lee, Doyeon Hwang, et al.
Circulation. Cardiovascular Interventions
|
May 24, 2024
Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial
Jung-Kyu Han, Seokhun Yang, Doyeon Hwang, et al.
JAMA Cardiology
|
November 27, 2024
Long-Term Aspirin vs Clopidogrel After Coronary Stenting by Bleeding Risk and Procedural Complexity
Jeehoon Kang, Jaewook Chung, Kyung Woo Park, et al.
Eclinicalmedicine
|
January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial
Jung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
BMJ Open
|
October 14, 2017
Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis - coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trial
Chi-Hoon Kim, Jung-Kyu Han, Han-Mo Yang, et al.
Biomaterials
|
December 23, 2019
NFATc1+CD31+CD45- circulating multipotent stem cells derived from human endocardium and their therapeutic potential
Han-Mo Yang, Ju-Young Kim, Hyun-Jai Cho, et al.
European Journal of Heart Failure
|
May 7, 2014
A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry
Sang Eun Lee, Hyun-Jai Cho, Hae-Young Lee, et al.
The American Journal of Cardiology
|
September 30, 2020
Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Jiesuck Park, Jung-Kyu Han, Jeehoon Kang, et al.
Page
of 20